SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-002092
Filing Date
2018-08-01
Accepted
2018-08-01 13:38:54
Documents
47
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gala_10q-053108.htm 10-Q 238249
2 CERTIFICATION gala_10q-3101.htm EX-31.1 11171
3 CERTIFICATION gala_10q-3201.htm EX-32.1 4771
  Complete submission text file 0001683168-18-002092.txt   1723050

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE glag-20180531.xml EX-101.INS 249502
5 XBRL SCHEMA FILE glag-20180531.xsd EX-101.SCH 22895
6 XBRL CALCULATION FILE glag-20180531_cal.xml EX-101.CAL 40848
7 XBRL DEFINITION FILE glag-20180531_def.xml EX-101.DEF 46629
8 XBRL LABEL FILE glag-20180531_lab.xml EX-101.LAB 165913
9 XBRL PRESENTATION FILE glag-20180531_pre.xml EX-101.PRE 131800
Mailing Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612
Business Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612 949-851-9261
Gala Pharmaceutical Inc. (Filer) CIK: 0001513403 (see all company filings)

IRS No.: 421771014 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 333-172744 | Film No.: 18984110
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl
Assistant Director 9